AGEN : Analysis & Opinions

  1. AstraZeneca Inks Immuno-Oncology Agreement with Omnis - Analyst ...

    January 14, 2015
    AstraZeneca (AZN) announced a deal with a privately held biotechnology company, Omnis Pharmaceuticals.
  2. Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics ...

    January 14, 2015
    Preliminary fourth quarter results and expectations for 2015 were key highlights in the biotech sector.
  3. Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst ...

    January 12, 2015
    Agenus (AGEN) inked a global license, development and commercialization agreement with Incyte Corporation for the development ...
  4. Agenus Jumps on Positive Data from Shingles Candidate - Analyst ...

    December 19, 2014
    Shares of Agenus Inc. (AGEN) jumped after its partner GlaxoSmithKline (GSK) announced encouraging results on HZ/su.
  5. SGEN/Takeda's Adcetris Progresses - Analyst Blog

    January 25, 2013
    Seattle Genetics Inc. (SGEN) and Takeda Pharmaceutical Company Limited (TKPYY) recently announced the commencement of a global ...
  6. Update on Orexigen's Contrave - Analyst Blog

    January 10, 2013
    Orexigen Therapeutics, Inc. (OREX) recently provided an update on its obesity candidate, Contrave. The company, which had ...
Trading Center